Purpose: To assess the effects of estrogen combined with biofeedback andelectrical stimulation.Methods: We selected60of postmenopausal patients who undergoing SUIbetween Oct.2011and Mar.2012were studied retrospectively in People’s Hospital ofLiaoning Province, the age is from40to55, the average age is47.5±5.20. Themenopausal life were2±6.4years. They were mild SUI and moderate SUI. All patientswere classified two groups: research group (n=30), who took the vaginal estrogen withBiofeedback and electric stimulation. The French Phenix USB8multifunctional pelvicfloor biofeedback device was used. To select the prescription of stress urinaryincontinence, the treatment time were20min. Estriol ointment was used in the vaginalwall after the end of treatment, each dose of0.5g, it was two times a week, a total of10times. And control group (n=30), who took biofeedback and electrical stimulation. After3and6months, compared the treatment of the two groups. The effects were testedthrough1hour pad test and I-CI-Q-SF. At the same time, the pelvic ultrasound wasused. By leakage of urine, urine leakage amount, calculated SUI score, the higher thescore, the worse the quality of life. All data were analyzed SPSS version17. P<0.05was considered statistically significant. The data are presented as mean±SD.Results: Before treatment, the amount of urine leakage of research group were8.5±2.03g. After3and6months, the amount of urine leakage of research group were4.97±1.38g,5.98±1.07g respectively. Significant differences (p<0.05) were found. Theamount of urine leakage of control group were9.1±2.32g, After3and6months, theamount of urine leakage of control group were6.04±1.19g、6.13±0.85g respectively.Significant differences (p<0.05) were found. The amount of urine leakage of researchgroup and control group were4.97±1.38g,6.04±1.19g, the amount of urine leakage of research group were less than the control group. After3months, p=0.037, significantdifferences (p<0.05) were found. The amount of urine leakage of research group andcontrol group were5.98±1.07g,6.13±0.85g,after6months. No significant differences(p>0.05) were found. Before treatment, the score of ICI-Q-SF of research group andcontrol group were8.7±2.02,8.9±2.31. t=3.797, p=0.898, No significant differences(p>0.05) were found. The score of ICI-Q-SF of research group and control group were4.01±1.48,5.95±1.61, after3months, t=1.243, p=0.042, significant differences (p<0.05)were found. The score of ICI-Q-SF of research group and control group were5.94±1.27,5.98±1.49, t=2.637, p=0.544, after6months. No significant differences (p>0.05) werefound. After3months, the score of ICI-Q-SF of research group were4.01±1.48,compared with pre-treatment, significant differences (p<0.05) were found. After6months, the score of ICI-Q-SF of research group were5.94±1.27, lower than thepre-treatment of urinary incontinence score (p<0.05). After3months, the score ofICI-Q-SF of control group were5.95±1.61, compared with pre-treatment, significantdifferences (p<0.05) were found. After6months, the score of ICI-Q-SF of control groupwere5.98±1.49. Compared with pre-treatment, significant differences (p<0.05) werefound. The endometrial thickness of research group were0.33±0.14cm. After3and6months, the endometrial thickness of research group were0.34±0.13cm,0.33±0.15cm.No significant differences (p>0.05) were found. The endometrial thickness of controlgroup were0.43±0.16cm. After3and6months, the endometrial thickness of researchgroup were0.49±0.14cm,0.46±0.15cm. No significant differences (p>0.05) werefound.Conclusions: Two treatment methods are effective for stress urinary incontinencein postmenopausal. After3months, compared to biofeedback and electric stimulation,estrogen combined biofeedback and electric stimulation were more effective in thetreatment of postmenopausal patients with stress urinary incontinence. After6months,the therapeutic effect of the two methods is similar. The treatment of estrogen combinedbiofeedback and electric stimulation were more applicable to postmenopausal women. |